Cargando…
Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study
BACKGROUND: Even in absence of obstructive coronary artery disease women with angina pectoris have a poor prognosis possibly due to coronary microvascular disease. Coronary microvascular disease can be assessed by transthoracic Doppler echocardiography measuring coronary flow velocity reserve (CFVR)...
Autores principales: | Mygind, Naja Dam, Michelsen, Marie Mide, Pena, Adam, Qayyum, Abbas Ali, Frestad, Daria, Christensen, Thomas Emil, Ghotbi, Adam Ali, Dose, Nynne, Faber, Rebekka, Vejlstrup, Niels, Hasbak, Philip, Kjaer, Andreas, Prescott, Eva, Kastrup, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096323/ https://www.ncbi.nlm.nih.gov/pubmed/27809867 http://dx.doi.org/10.1186/s12968-016-0295-5 |
Ejemplares similares
-
Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study
por: Mygind, Naja Dam, et al.
Publicado: (2016) -
Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction
por: Schroder, Jakob, et al.
Publicado: (2019) -
Overlap between angina without obstructive coronary artery disease and left ventricular diastolic dysfunction with preserved ejection fraction
por: Michelsen, Marie Mide, et al.
Publicado: (2019) -
Inflammation, non-endothelial dependent coronary microvascular function and diastolic function—Are they linked?
por: Suhrs, Hannah E., et al.
Publicado: (2020) -
Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study
por: Faber, Rebekka, et al.
Publicado: (2015)